Indeed, thiopurine use is associated with an increased risk for non-melanoma skin cancer (NMSC) and lymphoma [4,5,6,7], and anti-TNF use is associated with a higher risk for melanoma and lymphoma [8,9]. The gene discussed is TNF; the disease is melanoma.